O'Connor CM - Search Results

1

Depression and increased myocardial ischemic activity in patients with ischemic heart disease.

Jiang W, Babyak MA, Rozanski A, Sherwood A, O'Connor CM, Waugh RA, Coleman RE, Hanson MW, Morris JJ, Blumenthal JA. Jiang W, et al. Am Heart J. 2003 Jul;146(1):55-61. doi: 10.1016/S0002-8703(03)00152-2. Am Heart J. 2003. PMID: 12851608

2

Comparison of coronary artery bypass grafting versus medical therapy on long-term outcome in patients with ischemic cardiomyopathy (a 25-year experience from the Duke Cardiovascular Disease Databank).

O'Connor CM, Velazquez EJ, Gardner LH, Smith PK, Newman MF, Landolfo KP, Lee KL, Califf RM, Jones RH. O'Connor CM, et al. Am J Cardiol. 2002 Jul 15;90(2):101-7. doi: 10.1016/s0002-9149(02)02429-3. Am J Cardiol. 2002. PMID: 12106836

3

Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure.

Gattis WA, O'Connor CM, Leimberger JD, Felker GM, Adams KF, Gheorghiade M. Gattis WA, et al. Am J Cardiol. 2003 Jan 15;91(2):169-74. doi: 10.1016/s0002-9149(02)03104-1. Am J Cardiol. 2003. PMID: 12521629 Clinical Trial.

4

The problem of decompensated heart failure: nomenclature, classification, and risk stratification.

Felker GM, Adams KF Jr, Konstam MA, O'Connor CM, Gheorghiade M. Felker GM, et al. Am Heart J. 2003 Feb;145(2 Suppl):S18-25. doi: 10.1067/mhj.2003.150. Am Heart J. 2003. PMID: 12594448 Review.

5

Design considerations and proposed template for clinical trials in hospitalized patients with decompensated chronic heart failure.

O'Connor CM, Gattis WA, Teerlink JR, Adams KF Jr, Gheorghiade M. O'Connor CM, et al. Am Heart J. 2003 Feb;145(2 Suppl):S47-50. doi: 10.1067/mhj.2003.153. Am Heart J. 2003. PMID: 12594451 No abstract available.

6

Tezosentan in patients with acute heart failure and acute coronary syndromes: design of the fourth Randomized Intravenous Tezosentan Study (RITZ-4).

O'Connor CM, Gattis WA, Adams KF Jr, Shah MR, Frey A, Gheorghiade M; Randomized Intravenous Tezosentan Study Investigators. O'Connor CM, et al. Am Heart J. 2003 Feb;145(2 Suppl):S58-9. doi: 10.1067/mhj.2003.156. Am Heart J. 2003. PMID: 12594454 Clinical Trial. No abstract available.

7

Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure.

Trichon BH, Felker GM, Shaw LK, Cabell CH, O'Connor CM. Trichon BH, et al. Am J Cardiol. 2003 Mar 1;91(5):538-43. doi: 10.1016/s0002-9149(02)03301-5. Am J Cardiol. 2003. PMID: 12615256

8

Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?

Bourque JM, Velazquez EJ, Borges-Neto S, Shaw LK, Whellan DJ, O'Connor CM. Bourque JM, et al. Am Heart J. 2003 May;145(5):758-67. doi: 10.1016/S0002-8703(02)94818-0. Am Heart J. 2003. PMID: 12766731 Review.

9

Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure.

Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M, O'Connor CM. Felker GM, et al. Am J Cardiol. 2003 Sep 1;92(5):625-8. doi: 10.1016/s0002-9149(03)00740-9. Am J Cardiol. 2003. PMID: 12943893

10

Revascularization in patients with coronary artery disease, left ventricular dysfunction, and viability: a meta-analysis.

Bourque JM, Hasselblad V, Velazquez EJ, Borges-Neto S, O'connor CM. Bourque JM, et al. Am Heart J. 2003 Oct;146(4):621-7. doi: 10.1016/S0002-8703(03)00428-9. Am Heart J. 2003. PMID: 14564314

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,137 results

Search Page

Filters